tiprankstipranks
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market
RNTX
Rein Therapeutics
RESEARCH TOOLSreports
Holding RNTX?
Track your performance easily

Rein Therapeutics (RNTX) Technical Analysis

1,196 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Rein Therapeutics’s (RNTX) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Rein Therapeutics is a Sell.
Rein Therapeutics’s (RNTX) 20-Day exponential moving average is 2.17, while Rein Therapeutics’s (RNTX) share price is $2.1, making it a Buy.
Rein Therapeutics’s (RNTX) 50-Day exponential moving average is 2.37, while Rein Therapeutics’s (RNTX) share price is $2.1, making it a Buy.

Rein Therapeutics (RNTX) Pivot Points

Jan 29, 2025, 02:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.88
1.97
2.03
2.12
2.18
2.27
2.33
Fibonacci
1.97
2.02
2.06
2.12
2.17
2.21
2.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rein Therapeutics (RNTX) Moving Averages

Jan 29, 2025, 02:35 PM
Period
Simple
Exponential
MA5
2.29Buy
2.26Buy
MA10
2.14Buy
2.19Buy
MA20
2.14Buy
2.17Buy
MA50
2.31Buy
2.37Buy
MA100
2.88Sell
2.69Sell
MA200
3.06Sell
3.20Sell
Rein Therapeutics’s (RNTX) 10-Day exponential moving average is 2.19, while Rein Therapeutics’s (RNTX) share price is $2.1, making it a Buy.
Rein Therapeutics’s (RNTX) 100-Day exponential moving average is 2.69, while Rein Therapeutics’s (RNTX) share price is $2.1, making it a Sell.
Rein Therapeutics’s (RNTX) stock price is $2.1 and Rein Therapeutics’s (RNTX) 50-day simple moving average is 2.31, creating a Buy signal.
Rein Therapeutics’s (RNTX) stock price is $2.1 and Rein Therapeutics’s (RNTX) 100-day simple moving average is 2.88, creating a Sell signal.
Rein Therapeutics’s (RNTX) stock price is $2.1 and Rein Therapeutics’s (RNTX) 200-day simple moving average is 3.06, creating a Sell signal.

Rein Therapeutics (RNTX) Technical Indicators

Jan 29, 2025, 02:35 PM
Name
Value
Implied Action
RSI (14)
58.01
Neutral
STOCH (9,6)
52.39
Neutral
STOCHRSI (14)
52.39
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
25.33
Neutral
Williams %R
-19.63
Sell
CCI (14)
109.17
Sell
ATR (14)
0.26
-
Ultimate Oscillator
52.49
Neutral
ROC
19.14
Buy
Rein Therapeutics’s (RNTX) Relative Strength Index (RSI) is 58.01, creating a Neutral signal.
Rein Therapeutics’s (RNTX) Trend Strength Indicator (ADX) is 25.33, creating a Neutral signal.
Rein Therapeutics’s (RNTX) Commodity Channel Index (CCI) is 109.17, creating a Sell signal.
Rein Therapeutics’s (RNTX) Price Rate of Change (ROC) is 19.14, creating a Buy signal.

FAQ

Is RNTX a Buy, Hold, or Sell?
Based on RNTX’s technical indicators, RNTX is a Buy.
    What is RNTX’s RSI (14)?
    RNTX’s RSI (14) is 58.01, which suggests RNTX is a Neutral.
      What is RNTX’s MACD?
      RNTX’s MACD is -0.02, which suggests RNTX is a Sell.
        What is RNTX’s 5-day moving average?
        RNTX’s 5-day moving average is 2.29, which suggests RNTX is a Buy.
          What is RNTX’s 20-day moving average?
          RNTX 20-day moving average is 2.14, which suggests RNTX is a Buy.
            What is RNTX’s 50-day moving average?
            RNTX’s 50-day moving average is 2.31, which suggests RNTX is a Buy.
              What is RNTX’s 200-day moving average?
              RNTX’s 200-day moving average is 3.06, which suggests RNTX is a Sell.
                What is RNTX’s Williams % R (14)?
                RNTX’s Williams % R (14) is -19.63, which suggests RNTX is a Sell.
                  What is RNTX’s CCI (14)?
                  RNTX’s CCI (14) is 109.17, which suggests RNTX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis